>>Description of the research protocol "VAIN"

A prospective Interventional Pilot Study on the use of valpronic acid for treatment of idiopathic nephrotic syndrome (VAIN study)
Phase I study| Status : Ongoing (but closed to recruitment)

Additional details

Indication (or studied pathology) : Néphrologie clinique
Brugmann identifier : VAIN
EudraCT identifier : 2016-123456-12
ClinicalTrials.gov identifier : NCT02896270

Resources

Involved department : Nephrology-dialysis
Principal investigator : Wissing/Besse
Sponsor : UZ
Contact : Clinical Research Unit

>This protocol was approved by the UZ Brussel ethics committee.